HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Docking and 3D-QSAR investigations of pyrrolidine derivatives as potent neuraminidase inhibitors.

Abstract
Docking studies of pyrrolidine derivatives indicated that Trp178, Arg371, and Tyr406 were the key residues in the active pocket of influenza neuraminidase (NA). Hydrogen bond and electrostatic factors mainly influenced interactions between pyrrolidine derivatives and NA. Moreover, there was a significant correlation between binding affinity (total scores) and the experimental pIC(50) . Meanwhile, 3D-QSAR models of 87 pyrrolidine derivatives were developed to understand chemical-biological interactions governing their activities toward NA. Furthermore, R(2) , Q(2) , , and of the models were from 0.731 to 0.830, from 0.560 to 0.611, from 0.762 to 0.875, and from 0.649 to 0.856, respectively. QSAR modeling results elucidated that hydrogen bonds and electrostatic factors highly contributed to inhibitory activity, which was unanimous in the docking results.
AuthorsJiaying Sun, Hu Mei
JournalChemical biology & drug design (Chem Biol Drug Des) Vol. 79 Issue 5 Pg. 863-8 (May 2012) ISSN: 1747-0285 [Electronic] England
PMID22251826 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Copyright© 2012 John Wiley & Sons A/S.
Chemical References
  • Antiviral Agents
  • Pyrrolidines
  • Neuraminidase
  • pyrrolidine
Topics
  • Animals
  • Antiviral Agents (chemistry, pharmacology)
  • Binding Sites
  • Drug Design
  • Humans
  • Hydrogen Bonding
  • Models, Molecular
  • Neuraminidase (antagonists & inhibitors, chemistry, metabolism)
  • Orthomyxoviridae (drug effects, enzymology)
  • Orthomyxoviridae Infections (drug therapy, enzymology)
  • Pyrrolidines (chemistry, pharmacology)
  • Quantitative Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: